Skip to main content
Clinical Trials/DRKS00012868
DRKS00012868CompletedPhase 3

Efficacy of NSF on acute stress - NMC1-2017

MC Lab SAS0 sites20 target enrollmentStarted: August 11, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • pre-menopausal women must use hormonal contraception (for 3 months or more)

Exclusion Criteria

  • - smoker (> 5 cigarettes / day)
  • - any known allergies to the test substances
  • - any known addiction to drugs and alcohol
  • - hyper- or hypotension (except for those whose blood pressure is stable using medication for more than 3 months)
  • - known hyper- or hypothyroidism unless treated and under control (stable for more than 3 months)
  • - intake of dietary supplements or homoeopathic remedies during 2 weeks before V1
  • - on a strict diet or practicing sport, extensively
  • - any other known current/acute or chronic physical or psychological diseases besides minor medical conditions (e.g. seasonal allergies)
  • - subjects having previously participated in the TSST
  • - pregnant or lactating females or females planning a pregnancy within the next 3 months
  • - post-menopausal women using hormonal medication for less than 3 months
  • - employee of the sponsor or Clinical Research Organization (CRO)
  • - Investigator doubts truthfulness of self-reported health information
  • - not suitable because of limited verbal and cognitive abilities
  • - on vacation within the last 2 weeks

Investigators

Sponsor
MC Lab SAS

Similar Trials